| Study Name | Description | Trial Category | Trial SubCategory |
|---|---|---|---|
| A012301 | The purpose of this study is to compare low-dose tamoxifen versus standard-of-care endocrine therapy for 5 years to see if the recurrence-free interval is equivalent between groups, among post-menopausal women with early stage, low risk breast cancer. Follow-up continues for up to 10 years. | Cancer | Breast |
| A032201 | This study compares the addition of tivozanib to standard therapy pembrolizumab versus pembrolizumab alone for the treatment of patients with high-risk renal cell carcinoma (RCC). | Cancer | Renal |
| A092205 | This study compares the efficacy of cetuximab and pembrolizumab versus pembrolizumab alone in the treatment of recurrent and/or metatstatic head and neck squamous cell carcinoma. | Cancer | Head & Neck |
| EA5162 | This study aims to evaluate the safety and efficacy of osimertinib (AZD9291) among patients with non-small cell lung cancer with EGFR exon 20 insertions. | Cancer | Lung |
| EA5231 | This study compares adding AZD6738 to durvalumab versus durvalumab alone, following treatment with chemotherapy and surgery, in the treatment of patients with non-small cell lung cancer. | Cancer | Non-Small Cell Lung |
| NRG-GI011 | This study evaluates the overall survival rate of advanced pancreatic cancer patients who pursue dose-escalated radiation therapy versus standard treatment without dose-escalated radiation therapy at 3 years. | Cancer | Pancreatic |
| S1800E (LUNGMAP substudy) | This study is comparing a regimen of Docetaxel and Ramucirumab with or without Cemiplimab for participants with recurrent Non-Small Cell Lung Cancer, previously treated with platinum-basesd chemotherapy and immunotherapy. | Cancer | Non-Small Cell Lung |
| S1931 | This study evaluates adding surgery (radical or partial nephrectomy) to standard immunotherapy-based drug treatments for patients with metastatic renal cancer. | Cancer | Metastatic Renal |
| S2414 | This study compares disease free survival rate in patients treated with durvalumab after surgery versus observation only with early-stage non-small cell lung cancer. | Cancer | Non-Small Cell Lung |
| Easi-HF Preserved | The purpose of this study is to evaluate efficacy and safety of the combined use of oral Vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with symptomatic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) >= to 40% | Heart & Vascular | Atrial Fibrillation |
| QDOT | The purpose of this study is to evaluate the long-term safety and effectiveness of the QDOT Micro system use in conjunction with Visitag Surpoint Module for the treatment of symptomatic drug refractory Paroxysmal Atrial Fibrillation. | Heart & Vascular | Atrial Fibrillation |
| SOS Maternity | This purpose of this study is to provide interventions to reduce the rate of preeclampsia and preterm birth across Michigan's health care systems. | OB/GYN | Obstetrics (OB) |
| Vanquish 2 | This is a study to evaluate the efficacy and safety of VK2735, administered subcutaneously, for weight management in adults with Type 2 Diabetes. | Diabetes | Obesity and Type 2 Diabetes |
| A071701 | This study is for patients who brain metastasis. Patients must have an actionable alteration in NTRK, ROS1, KRAS G12C or CDK pathway or P13K. | Cancer | Brain Mets |
| A072201 | This study if for patients with recurrent glioblastomas. It is looking at standard of care treatment (Lomustine) vs Anti-LAG-3 and Anti-PD-L1 Blockade. | Cancer | Glioblastoma |
| NRG GU013 | This study is for patients with high risk prostate cancer. PSA must be >20 ng/ml. Patient must have a Gleason score of 8-10. Patient cannot have metastatic disease outside of pelvic lymph nodes. No prior radiation or androgen deprivation therapy allowed. | Cancer | Prostate |
| NRG-GU011 | The purpose of this study is to look at adding Androgen deprivation therapy in patients with prostate cancer with only a few areas of metastasis. You must have had prior curative intent treatment to the prostate. | Cancer | Prostate |
| RTOG 1216 | This study is for patients with squamous cell cancer of the head and neck. It looks at after surgery adding radiation to the standard of care chemotherapy to treat the cancer. | Cancer | Head & Neck |
| S1900G (LUNGMAP substudy) | The purpose of this study is to determine if adding ramucirumab in combination with capmatinib and osimertinib is effective in treating patients with Stage 4 or recurrent non-small cell lung cancer. | Cancer | Metastatic Non-Small Cell Lung |
| S1900J (LUNGMAP substudy) | The purpose of this study is see if Amivanatamab is effective in treating patients with MET-Amplification Positive Stage 4 or recurrent non-small cell lung cancer. | Cancer | Metastatic Non-Small Cell Lung |
| S1900K (LUNGMAP substudy) | The purpose of this study is to determine if the use of Tepotinib with or without Ramucirumab is effective in patients with MET Exon 14 skipping positive stage 4 or recurrent non-small cell lung cancer (NSCLC).(LUNGMAP sub-study) | Cancer | Metastatic Non-Small Cell Lung |
| S2312 | This study is for patients with metastatic prostate cancer. It looks at using Cabazitaxel with or without carboplatin in patients with castrate-resistant prostate cancer. | Cancer | Prostate |
| S2303 | This study is for patients who have progressed on standard of care treatment for gastric or esophageal cancer. The study looks at adding Nivolumab to 2nd line treatment to see if it improves outcomes. | Cancer | Gastric or Esophageal |
| Basic | The purpose of this study is to test if different mobile or wearable devices can measure how much time a person's heart is in atrial fibrillation over a period of 4 months. | Heart & Vascular | Atrial Fibrillation |
| Picasso | The study is trying to assess the safety and efficacy of fixing the narrowing in your carotid artery using a stent versus using a balloon or suction method when performed at the same time as the mechanical thrombectomy. | Neurosciences | Stroke |
| EA5221 | The purpose of this study is to determine in the older adult population if immunotherapy alone is better than immunotherapy + chemotherapy. Patients must be 70+ with diagnosis of Non-Small Cell Lung Cancer. | Cancer | Non-Small Cell Lung Cancer |
| NRG BN011 | The purpose of this study is to determined if combination therapy radiation is more effective than single agent therapy with radiation. Patients must be diagnosed with a Methylated MGMT promoter Gliblastoma. | Cancer | Gliblastoma |
| NRG CC011 | This study is for patients with stage 1-3 breast cancer. Patient must be > 6 months to 5 years out from treatment and experiencing symptoms of brain fog. The study using cognitive training to try to improve brain fog symptoms. | Cancer | Breast |
| Librexia ACS | The purpose of this study is to see if an experimental drug, called milvexian is safe, effective and useful in reducing risk of developing blood clots, stroke, or another heart attack among subjects with a recent heart attack or angina (chest pain) episode. An experimental drug is one that is not approved by the United States Food and Drug Administration (FDA). | Heart & Vascular | Atrial Fibrillation |
| A032103 | The purpose of this study is to use central DNA testing to monitor recurrance in patients with urothelial cancer. You must have had a radical cysectomy and lymph node dissection with no evidence of residual cancer. | Cancer | Urothelial |
Unsupported Browser! This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.